APA استشهاد

Nagano, T., Kotani, Y., Kobayashi, K., Katsurada, M., Hatakeyama, Y., Hori, S., . . . Nishimura, Y. (2011). Successful Erlotinib Treatment for a Patient with Gefitinib-Related Hepatotoxicity and Lung Adenocarcinoma Refractory to Intermittently Administered Gefitinib. Hindawi Publishing Corporation.

استشهاد بنمط شيكاغو

Nagano, Tatsuya, et al. Successful Erlotinib Treatment for a Patient With Gefitinib-Related Hepatotoxicity and Lung Adenocarcinoma Refractory to Intermittently Administered Gefitinib. Hindawi Publishing Corporation, 2011.

MLA استشهاد

Nagano, Tatsuya, et al. Successful Erlotinib Treatment for a Patient With Gefitinib-Related Hepatotoxicity and Lung Adenocarcinoma Refractory to Intermittently Administered Gefitinib. Hindawi Publishing Corporation, 2011.

تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.